EGFR and non-small cell lung carcinoma: Targeted NGS of cancer-relevant genes in the CSF of NSCLC patients with central nervous system metastasis revealed that CSF had higher sensitivity for identifying actionable driver mutations than plasma [195], and CSF was reported to be a more representative liquid biopsy sample type for LM in the context of EGFR-mutant NSCLC [191].